Menopause and the Drug Companies — NK3 receptor antagonists (Think Veozah)

I love sitting here at the computer doing menopause research. It leads to such fascinating things. The first thing I googled today was: What menopause products are drug companies working on.

I think we should talk about the results of that search. There is a lot to pay attention to. Grab a snack.

The first thing that appeared in my search was this headline from PharmaVoice Published July 5, 2023:

“Women’s healthcare investments are hot. So where are the new menopause drugs?

NK3 receptor antagonists offer a new option, but experts say more are needed.”

Here is the link: https://www.pharmavoice.com/news/menopause-treatment-Astellas-Bayer/684911/

Astrellas Pharma, in Japan, run by Japanese MEN, own Veozah, a subsidiary of some sort, of the Mitsubishi UFJ Financial Group (MUFJ). Money guys selling us menopause drugs.

And apparently, Bayer is coming up with another NK3 receptor antagonist, elinzanetant (a hot flash drug). Bayer. Remember they bought Monsanto. Monsanto is the pesticide company. Try not to forget who they really are.

Ok…these drugs regulate your temperature. What if you are sick and you need to have a fever? I cannot find any…